首页> 外文OA文献 >Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine

【2h】

Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine

机译：HIV亚型对未接受抗逆转录病毒治疗的成年人的反应和耐药性的影响，比较每日一次与每日两次利托那韦联合阿巴卡韦/拉米夫定联合利托那韦加强用药的fosamprenavir

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Lisa L. Ross; William G. Nichols; Naomi Givens; Graeme Moyle; Giampiero Carosi; Hans-Juergen Stellbrink; Adriano Lazzarin; Marjorie D. Robinson;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of HIV subtype on response and resistance in antiretroviral-na?ve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine [J] . Lisa L. Ross, Marjorie D. Robinson, Giampiero Carosi, Drugs and Therapy Studies . 2012 ,第1期

机译：与单纯阿托巴韦/拉米夫定联合利托那韦每日一次和每日两次利福那韦加强治疗相比，艾滋病毒亚型对未接受抗逆转录病毒治疗的成年人的反应和耐药性的影响
2. Study of once-daily versus twice-daily fosamprenavir plus ritonavir administered with abacavir/lamivudine once daily in antiretroviral-naive HIV-1-infected adult subjects. [J] . Nichols HIV clinical trials . 2009 ,第6期

机译：在未经抗逆转录病毒治疗的HIV-1感染的成年受试者中，每天一次与每天两次两次服用fosamprenavir加ritonavir联合阿巴卡韦/拉米夫定的研究。
3. Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study. [J] . Moyle GJ, DeJesus E, Cahn P, JAIDS: Journal of acquired immune deficiency syndromes . 2005 ,第4期

机译：每天一次或两次阿巴卡韦联合每天一次的拉米夫定和依非韦伦联合治疗抗逆转录病毒初次感染HIV的成年人：Ziagen每日一次的抗逆转录病毒联合研究结果。
4. Once-daily Nadroparin Versus Twice-daily Nadroparin in the Treatment of Patients with Acute Coronary Syndromes: The SAFRAX Study [C] . V. Hricak, A. Leizorovic International Congress on Thrombosis . 2006

机译：每日一日奈多林与每次每日Nadroparin治疗患者急性冠状动脉综合征患者：Safrax研究
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Impact of Low Abundance HIV Variants on Response to Ritonavir-Boosted Atazanavir or Fosamprenavir Given Once Daily with Tenofovir/Emtricitabine in Antiretroviral-Naive HIV-Infected Patients [O] . Lisa L. Ross, Winkler G. Weinberg, Edwin DeJesus, -1

机译：低天数HIV变体对初次使用抗逆转录病毒HIV感染的替诺福韦/恩曲他滨每日一次给予利托那韦增强的阿扎那韦或氟桑那韦的反应的影响
7. Impact of Low Abundance HIV Variants on Response to Ritonavir-Boosted Atazanavir or Fosamprenavir Given Once Daily with Tenofovir/Emtricitabine in Antiretroviral-Naive HIV-Infected Patients [O] . Ross, Lisa L., Weinberg, Winkler G., DeJesus, Edwin, 2010

机译：低天数HIV变体对初次使用抗逆转录病毒HIV感染的替诺福韦/恩曲他滨每日一次给予利托那韦增强的Atazanavir或Fosamprenavir反应的影响

Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine

著录项

相似文献

相关主题

期刊订阅